Zoetis' pharmaceutical segment encompasses a wide array of therapeutic solutions designed to prevent and treat diseases in both livestock and companion animals. This includes anti-infectives, parasiticides, pain and sedation medications, and other pharmaceutical products addressing various health conditions. Research and development efforts focus on identifying novel drug targets, developing innovative formulations, and conducting clinical trials to ensure safety and efficacy. Technologies such as advanced drug delivery systems and precision medicine approaches are employed to optimize treatment outcomes. The segment aims to improve animal welfare, enhance productivity in livestock farming, and provide effective solutions for pet owners, contributing to the overall health and well-being of animals worldwide. Regulatory compliance and adherence to quality standards are paramount in this segment.

The vaccine segment at Zoetis focuses on developing and manufacturing biological preparations that prevent infectious diseases in animals. These vaccines target a range of pathogens affecting livestock, such as cattle, swine, and poultry, as well as companion animals like dogs and cats. R&D activities involve identifying key viral and bacterial antigens, developing effective vaccine formulations, and conducting rigorous testing to ensure immunogenicity and safety. Technologies employed include recombinant DNA technology, adjuvants to enhance immune responses, and advanced manufacturing processes to produce high-quality vaccines. The segment plays a crucial role in preventing disease outbreaks, reducing the need for antibiotic use, and improving animal health outcomes. By providing effective preventative solutions, Zoetis contributes to sustainable livestock production and the well-being of pets.

Zoetis' diagnostics segment provides a comprehensive suite of products and services for animal health monitoring and disease detection. This includes point-of-care diagnostic instruments, rapid immunoassay tests, reference laboratory services, and blood glucose monitors. Research and development efforts focus on developing innovative diagnostic assays, improving the accuracy and speed of testing, and integrating data analytics to provide actionable insights. Technologies employed include molecular diagnostics, immunoassay techniques, and advanced imaging systems. The segment supports veterinarians in making informed decisions, enabling early disease detection, and improving treatment outcomes. By providing accurate and timely diagnostic information, Zoetis contributes to better animal health management and enhanced veterinary care.